TITLE

Cutaneous Administration of Nitroglycerin in Patients with Angina Pectoris

AUTHOR(S)
Davidov, Michael E.
PUB. DATE
January 1981
SOURCE
Angiology;Jan1981, Vol. 32 Issue 1, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents information on cutaneous administration of nitroglycerin in patients with angina pectoris. The investigation reported here evaluated the effect of cutaneously administered nitroglycerin ointment at 1-, 5-, and 8-hour intervals after drug administration by means of a standardized protocol with graded exercise tests. Clinical experience has suggested that the duration of action of 2% nitroglycerin ointment is substantially longer than 3 hours. However, review of the available medical literature revealed that clinical and laboratory testing has been limited to 3 hours after cutaneous nitroglycerin administration.
ACCESSION #
16390046

 

Related Articles

  • Cold Pressor Test and Variant Angina. Kawano, Tomoki; Okabe, Masanori; Arakawa, Kikuo // Angiology;Jul1983, Vol. 34 Issue 7, p429 

    A transient complete coronary occlusion due to spasm was induced by the cold pressor test in a 51-year-old man with variant angina. Arteriography before the test revealed a normal left coronary artery and only minor irregularities of the mid-portion of the right coronary artery. Three minutes...

  • Ranolazine extended release is a useful adjunct in the treatment of chronic stable angina pectoris.  // Drugs & Therapy Perspectives;Jan2007, Vol. 23 Issue 1, p1 

    Ranolazine extended release (ER) is indicated for the combination treatment of chronic stable angina in patients who have not achieved an adequate response with other antianginals. As add-on therapy with other antianginals, ranolazine ER improves exercise tolerance, reduces the frequency of...

  • Nitroglycerin Transdermal Patch.  // AHFS Consumer Medication Information;May2017, p1 

    Nitroglycerin transdermal patches are used to prevent episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). Nitroglycerin transdermal patches can only be used to prevent attacks of angina; they cannot be used...

  • Nitroglycerin Sublingual.  // AHFS Consumer Medication Information;May2017, p1 

    Nitroglycerin spray and tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). The spray and tablets may also be taken just before activities that may cause episodes of angina in order...

  • Prinzmetal's angina.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1893 

    A reference entry for the medical term "Prinzmetal's angina," another word for variant angina, is presented.

  • A Twitch of the Heart. KAGAN, H. LEE // Discover;Nov2012, Vol. 33 Issue 9, p26 

    The author describes his attempts to diagnose a rare heart disease in a 31-year-old woman experiencing chronic chest pains. The patient collapsed with brachycardia during a cardiac stress test to detect evidence of coronary artery disease (CAD), but an angiogram revealed no CAD or heart attack....

  • THE ONSET AND DURATION OF ACTION OF CLONITRATE AS MEASURED BY THE BALLISTOCARDIOGRAPHIC RESPONSE. Krasno, Louis R.; Kidera, George J. // Angiology;May1965, Vol. 16 Issue 5, p233 

    It has been pointed out that since the ballistocardiogram records the combined hemodynamic response of the force of the heart and peripheral vascular resistance, it is particularly suitable for measuring the response of an agent which acts on both the myocardium and the peripheral blood vessels....

  • PRELIMINARY INVESTIGATION OF PHENELZINE IN THE MANAGEMENT OF ANGINA PECTORIS. Ende, Milton // Angiology;Feb1960 Part 2, Vol. 11 Issue 1, p81 

    Twenty patients with angina, pectoris of varying degrees of severity were treated with phenelzine for a period of 3 months. The dosage of phenelzine in all cases was 15 mg three times daily. Six of the 20 patients experienced complete remission of symptoms, in another 11 patients, the frequency...

  • STUDIES ON A NEW CORONARY VASODILATOR; l-CHLORO-2,3-PROPANEDIOL DINITRATE. Burgison, Raymond M.; Lu, Gordon G.; Cowley, R. Adams; Krantz Jr., John C. // Angiology;Sep1962, Vol. 13 Issue 9, p412 

    Focuses on the development of a new coronary vasodilator, 1-chloro-2,3-propanediol dinitrate, for the treatment of angina pectoris. Capacity of the compound to provide a longer duration of vasodilation with less concomitant side-effects; Materials and methods for the development of the new...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics